Ashi Anand, CEO of IME Capital, highlights the overvaluation in smallcaps and recent correction. Despite a 20% fall, valuations remain high. Anand suggests a long-term perspective for buying opportunities. Tariffs by Trump may impact IT and pharma sectors, but exact outcomes remain uncertain.
Mcap of 8 of top-10 firms erodes by Rs 1.55L cr
Recently, the market witnessed a downturn, with eight of the leading firms in India suffering major valuation losses. The declines of HDFC Bank and Bajaj